The Vanguard Group 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | Anika Therapeutics, Inc. ANIK |
The Vanguard Group | 764,045 5.220% |
-219,723 (-22.33%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Anika Therapeutics, Inc. ANIK |
The Vanguard Group | 983,768 6.730% |
17,855 (+1.85%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
The Vanguard Group | 965,913 6.690% |
31,631 (+3.39%) |
Filing |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
The Vanguard Group | 934,282 6.570% |
18,686 (+2.04%) |
Filing |